- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06088498
App for Reducing Cravings to Smoke
February 5, 2026 updated by: H. Lee Moffitt Cancer Center and Research Institute
Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
The overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The aims of the study are: (1) to update a recently developed study-related smartphone application to reduce cravings to smoke to be an engaging, user-friendly treatment tool, and verify user satisfaction; and (2) to test in a randomized controlled trial the efficacy of the app as an adjunct to quitline smoking cessation treatment in improving smoking abstinence compared to the quitline only.
Study Type
Interventional
Enrollment (Estimated)
3600
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christine Vinci, PhD
- Phone Number: 813-745-5421
- Email: Christine.Vinci@moffitt.org
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Recruiting
- Moffitt Cancer Center
-
Sub-Investigator:
- Steve Sutton, PhD
-
Sub-Investigator:
- Kea Turner, PhD
-
Contact:
- Karen Brandon
- Phone Number: 813-745-7691
- Email: karen.brandon@moffitt.org
-
Principal Investigator:
- Christine Vinci, PhD
-
Sub-Investigator:
- Thomas Brandon, PhD
-
Sub-Investigator:
- Margaret Byrne, PhD
-
Sub-Investigator:
- Damon Vadrine, DRPH
-
Sub-Investigator:
- Lee Ritterbrand, PhD
-
Sub-Investigator:
- Kara Wiseman, PhD, MPH
-
Sub-Investigator:
- Katrina Vickerman, PhD
-
Contact:
- Marilyn Horta, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- >18 years of age
- Daily smokers that have quit smoking within the past 3 months (Aim 1) or currently smoking ≥ 3 cigarettes per day for the past year (Aim 2)
- Functioning telephone number
- Owns a smart phone capable of supporting AR and willing to download the app
- Can speak, read and write in English
Exclusion Criteria:
- Has another household member already enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aim 1: Update an existing smartphone App
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction.
|
In addition to quitline services, participants will download a study app that will allow them to track smoking urges and abstinence.
After 48 hours of self-reported abstinence, those in the intervention group will be exposed to smoking extinction trials through the study smartphone app.
|
|
Experimental: Aim 2: Quit Line Only
Participants randomized to this arm will receive usual care for smoking cessation via the quitline and a smartphone app that will allow them to track smoking urges and abstinence.
|
Quitline coaches use cognitive behavioral therapy, reinforcement, and principles of self-efficacy to promote effective behavior change.
The quitline approach includes 5 key elements: setting a quit date, coping with triggers, effectively using medications, tobacco proofing, and social support.
Individuals who enroll in the quitline's multi-call program receive phone calls and NRT.
|
|
Experimental: Aim 2:Quitline plus smartphone App
Participants randomized to this arm will receive usual care for smoking cessation via the quitline and a smartphone app that will allow them to track smoking urges and abstinence.
After 48 hours of self-reported abstinence, they will be exposed to smoking extinction trials through the study smartphone app.
|
In addition to quitline services, participants will download a study app that will allow them to track smoking urges and abstinence.
After 48 hours of self-reported abstinence, those in the intervention group will be exposed to smoking extinction trials through the study smartphone app.
Quitline coaches use cognitive behavioral therapy, reinforcement, and principles of self-efficacy to promote effective behavior change.
The quitline approach includes 5 key elements: setting a quit date, coping with triggers, effectively using medications, tobacco proofing, and social support.
Individuals who enroll in the quitline's multi-call program receive phone calls and NRT.
Participants will be asked to use a recently developed study smartphone application to reduce cravings to smoke for a 5-week period.
Through the app, participants will be exposed to smoking extinction trials daily.
Participants will be encouraged and reminded to complete 2-5 extinction sessions per day.
Each session will present 3-8 cues, and each cue will be presented for 20-40 seconds (average amount of extinction per day will be about 10 minutes).
Participants will be encouraged to conduct the extinction sessions when high cravings are expected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (Aim 1)
Time Frame: At 1 Week
|
Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale.
Scores range from 0 to 100, with higher scores indicating better usability.
|
At 1 Week
|
|
Tobacco Abstinence (Aim 2)
Time Frame: At 6 Months
|
Self-report of no combustible tobacco use in the past 7 days
|
At 6 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
User Satisfaction (Aim 1)
Time Frame: At 1 Week
|
One Likert scale item will capture participants' satisfaction with the app.
The Likert scale is from 1 to 4, with higher score indicating greater satisfaction.
|
At 1 Week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Christine Vinci, PhD, Moffitt Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 11, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Study Registration Dates
First Submitted
October 12, 2023
First Submitted That Met QC Criteria
October 12, 2023
First Posted (Actual)
October 18, 2023
Study Record Updates
Last Update Posted (Actual)
February 9, 2026
Last Update Submitted That Met QC Criteria
February 5, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- MCC-21980 Aim 2
- R01DA055298 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.